MPLT today
$7.25+$0.18 (+2.55%)close Nov 13, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bearish
1 hourAscending Triangle
15 minBullish
5 minSymmetric Triangle
Daily trend turns up above $8.58
Key levels
Resistance$8.58
Resistance$7.46
Support$6.06
Latest news & SEC filings
AnalystGuggenheim starts MapLight Therapeutics coverage with Neutral rating
All MPLT news →About MapLight Therapeutics
MapLight Therapeutics is a drug developer focused on disorders of the brain and nervous system. Its most advanced experimental medicine, ML-007C-MA, is being tested in mid-stage studies for schizophrenia and for psychosis tied to Alzheimer's disease. Another program, ML-004, targets social difficulties in autism spectrum disorder. Earlier research efforts address neuropsychiatric and movement-related conditions. The company is based in the United States and holds worldwide rights to its programs.
Based on the company's 10-K filed Mar 26, 2026.
Nasdaq · Healthcare
MapLight Therapeutics, Inc. (MPLT)
What Is the Price Target for MPLT?
SEPT Low Target
$13.00
SEPT Mid Target
$36.00
SEPT High Target
$46.00
Analyst Consensus
$36.00
Is MPLT a Buy or Sell Right Now?
Thesis
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MPLT.
Start Free Trial →Is MPLT Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$36.00
12
Moat Score
NONE
4/9
Piotroski Score
0.2
Altman Z-Score
What Is Smart Money Doing with MPLT?
Insider Signal
SELLING
0 buys / 20 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| GILLIS JONATHAN | officer | Sale | 10,167 | $82K | Oct 15, 2026 |
| Lillie James Woodruff | officer | Sale | 11,513 | $93K | Oct 15, 2026 |
| Kroeger Christopher A. | director officer | Sale | 73,691 | $595K | Oct 15, 2026 |
| Kreitzer Anatol | officer | Sale | 12,248 | $96K | Oct 15, 2026 |
| Foff Erin Pennock | officer | Sale | 15,355 | $124K | Oct 15, 2026 |
| Hanson Kristopher | officer | Sale | 9,020 | $73K | Oct 15, 2026 |
| Hanson Kristopher | officer | Sale | 16,509 | $193K | Sep 16, 2026 |
| Kroeger Christopher A. | director officer | Sale | 118,037 | $3.2M | May 18, 2026 |
| Kroeger Christopher A. | director officer | Sale | 198 | $6K | May 18, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →MPLT Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
82.39%
FCF Growth YoY
-74.2%
Revenue Trend
UNKNOWN
Dark Pool Trades for MPLT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for MPLT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 20:43:17 | $7.13 | 7,300 | $$52K | BUY |
| 19:55:09 | $7.17 | 1,008 | $$7K | SELL |
| 19:15:33 | $7.26 | 2,013 | $$15K | BUY |
| 18:31:20 | $7.36 | 1,000 | $$7K | BUY |
| 18:14:35 | $7.23 | 1,087 | $$8K | MIDPOINT |
5 dark pool trades shown · $$89K preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for MPLT
PREVIEWSEPT Investing provides real-time options flow tracking for MPLT, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $10 | May 21 | 190 | $$400 | 1 | SWEEP |
| PUT | $10 | May 21 | 190 | $$400 | 1 | SWEEP |
| PUT | $10 | May 21 | 190 | $$400 | 1 | SWEEP |
3 options trades shown · 0% calls
Unusual activity, GEX levels, max pain, and dealer positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for MapLight Therapeutics, Inc. (MPLT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →MPLT — frequently asked questions
What is MPLT stock price today?
MapLight Therapeutics, Inc. (MPLT) is at $7.25, up 2.55% (+$0.18) at the Nov 13, 2026 close.
Why is MPLT stock moving today?
Latest MPLT news — Oct 6, 2026: Guggenheim starts MapLight Therapeutics coverage with Neutral rating
What is the MPLT price target?
The average analyst price target for MPLT is $36.00, ranging from $13 to $46, based on 9 analysts. Latest: Needham maintains on Aug 31, 2026.
What do analysts rate MPLT?
Analyst ratings for MPLT: 0 Buy, 17 Hold, 2 Sell — consensus Hold.
Did MPLT beat earnings?
MPLT last reported on Sep 18, 2026: EPS -$1.32 vs -$1.35 expected — a beat of 2.2%.
What is MPLT's P/E ratio?
MPLT trades at a P/E of 0.1 vs a Healthcare average of 17.7.
Does MPLT pay a dividend?
MPLT does not currently pay a dividend.
What are MPLT support and resistance levels?
Support: $6.06. Resistance: $7.46, $8.58, $10.13.
What are insiders doing with MPLT?
Insider activity: SELLING, 0 buys and 20 sells in the last 90 days.
What is the latest news on MPLT?
Oct 6, 2026: Guggenheim starts MapLight Therapeutics coverage with Neutral rating